Pages that link to "Q36379316"
Jump to navigation
Jump to search
The following pages link to Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells. (Q36379316):
Displayed 15 items.
- High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small Molecules (Q37272414) (← links)
- AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency (Q38650841) (← links)
- Gene correction in patient-specific iPSCs for therapy development and disease modeling (Q38852141) (← links)
- Emerging cellular and gene therapies for congenital anemias. (Q38993825) (← links)
- May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells (Q39126523) (← links)
- Therapeutic gene editing: delivery and regulatory perspectives (Q39230418) (← links)
- A history of genome editing in mammals. (Q39356164) (← links)
- Modeling rare diseases with induced pluripotent stem cell technology. (Q47747683) (← links)
- Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency (Q64042578) (← links)
- Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells (Q90695946) (← links)
- Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA (Q90744990) (← links)
- Establishment of microRNA, transcript and protein regulatory networks in Alport syndrome induced pluripotent stem cells (Q93357153) (← links)
- PB2.33 (Q98128484) (← links)
- PKD2.78 (Q98128608) (← links)
- PKD3.54 (Q98128609) (← links)